These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34677722)

  • 1. Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan.
    Lahav E; Shahrabani S; Rosenboim M; Tsutsui Y
    Eur J Health Econ; 2022 Jun; 23(4):687-703. PubMed ID: 34677722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel.
    Heller O; Chun Y; Shlomo Y; Gewirtz-Meydan A; Acri M; Kulkarni S; Grinstein-Weiss M
    Vaccine; 2022 Mar; 40(13):2053-2061. PubMed ID: 35168839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Israel's rapid rollout of vaccinations for COVID-19.
    Rosen B; Waitzberg R; Israeli A
    Isr J Health Policy Res; 2021 Jan; 10(1):6. PubMed ID: 33499905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of religiosity in COVID-19 vaccine hesitancy.
    Garcia LL; Yap JFC
    J Public Health (Oxf); 2021 Sep; 43(3):e529-e530. PubMed ID: 34080617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological factors underpinning vaccine willingness in Israel, Japan and Hungary.
    Goodwin R; Ben-Ezra M; Takahashi M; Luu LN; Borsfay K; Kovács M; Hou WK; Hamama-Raz Y; Levin Y
    Sci Rep; 2022 Jan; 12(1):439. PubMed ID: 35013430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel's COVID-19 vaccination program.
    Rosen B; Waitzberg R; Israeli A; Hartal M; Davidovitch N
    Isr J Health Policy Res; 2021 Aug; 10(1):43. PubMed ID: 34340714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intentions to be Vaccinated Against COVID-19: The Role of Prosociality and Conspiracy Beliefs across 20 Countries.
    Enea V; Eisenbeck N; Carreno DF; Douglas KM; Sutton RM; Agostini M; Bélanger JJ; Gützkow B; Kreienkamp J; Abakoumkin G; Abdul Khaiyom JH; Ahmedi V; Akkas H; Almenara CA; Atta M; Bagci SC; Basel S; Berisha Kida E; Bernardo ABI; Buttrick NR; Chobthamkit P; Choi HS; Cristea M; Csaba S; Damnjanovic K; Danyliuk I; Dash A; Di Santo D; Faller DG; Fitzsimons G; Gheorghiu A; Gómez Á; Grzymala-Moszczynska J; Hamaidia A; Han Q; Helmy M; Hudiyana J; Jeronimus BF; Jiang DY; Jovanović V; Kamenov Ž; Kende A; Keng SL; Kieu TTT; Koc Y; Kovyazina K; Kozytska I; Krause J; Kruglanski AW; Kurapov A; Kutlaca M; Lantos NA; Lemay EP; Lesmana CBJ; Louis WR; Lueders A; Malik NI; Martinez A; McCabe KO; Mehulić J; Milla MN; Mohammed I; Molinario E; Moyano M; Muhammad H; Mula S; Muluk H; Myroniuk S; Najafi R; Nisa CF; Nyúl B; O'Keefe PA; Osuna JJO; Osin EN; Park J; Pica G; Pierro A; Rees J; Reitsema AM; Resta E; Rullo M; Ryan MK; Samekin A; Santtila P; Sasin E; Schumpe BM; Selim HA; Stanton MV; Sultana S; Tseliou E; Utsugi A; van Breen JA; Van Lissa CJ; Van Veen K; vanDellen MR; Vázquez A; Wollast R; Yeung VW; Zand S; Žeželj IL; Zheng B; Zick A; Zúñiga C; Leander NP
    Health Commun; 2023 Jul; 38(8):1530-1539. PubMed ID: 35081848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of COVID-19 vaccination intentions: Attitudes, institutional trust, fear, conspiracy beliefs, and vaccine skepticism.
    Seddig D; Maskileyson D; Davidov E; Ajzen I; Schmidt P
    Soc Sci Med; 2022 Jun; 302():114981. PubMed ID: 35512613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hope as a predictor for COVID-19 vaccine uptake.
    Mayer Y; Etgar S; Shiffman N; Bloch Y; Mendlovic S; Lurie I
    Hum Vaccin Immunother; 2021 Dec; 17(12):4941-4945. PubMed ID: 34714728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of COVID-19 vaccine acceptance among adults with diabetes and in the general population in Israel: A cross-sectional study.
    Kolobov T; Djuraev S; Promislow S; Tamir O
    Diabetes Res Clin Pract; 2022 Jul; 189():109959. PubMed ID: 35714724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel.
    Kuodi P; Gorelik Y; Zayyad H; Wertheim O; Beiruti Wiegler K; Abu Jabal K; Dror AA; Elsinga J; Nazzal S; Glikman D; Edelstein M
    Sci Rep; 2023 Sep; 13(1):15801. PubMed ID: 37737268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parents' hesitation about getting their children vaccinated against COVID-19 in Japan.
    Yoda T; Katsuyama H
    Hum Vaccin Immunother; 2021 Dec; 17(12):4993-4998. PubMed ID: 34623937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Israel's grim warning: Delta can overwhelm shots.
    Wadman M
    Science; 2021 Aug; 373(6557):838-839. PubMed ID: 34413215
    [No Abstract]   [Full Text] [Related]  

  • 17. The Link Between COVID-19, Anxiety, and Religious Beliefs in the United States and the United Kingdom.
    Rigoli F
    J Relig Health; 2021 Aug; 60(4):2196-2208. PubMed ID: 34050906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
    Abu Jabal K; Ben-Amram H; Beiruti K; Brimat I; Abu Saada A; Bathish Y; Sussan C; Zarka S; Edelstein M
    Epidemiol Infect; 2021 Aug; 149():e239. PubMed ID: 34399868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.